35 devices · GMDN 63739
Uroplakin IVD antibody devices are laboratory tests designed to detect uroplakin proteins in clinical samples, such as urine or tissue specimens. Clinically, they help diagnose or monitor conditions like bladder cancer by identifying specific biomarkers linked to uroplakin expression, aiding in early detection or treatment assessment.
These devices are typically in-vitro diagnostics (IVDs) regulated as medical devices rather than drugs, with classification and supply depending on jurisdiction. They are used in research or clinical settings and may require validation for accuracy before deployment, though specifics vary by country or region.
This category summary is AI-generated from the GMDN nomenclature and has not been verified by a human reviewer.